Natriumbenzylpenicilline Sandoz (Benzylpenicillin Sodium)

Benzylpenicillin sodium inhibits bacterial cell wall synthesis by binding to penicillin‑binding proteins on the bacterial membrane. This blocks the cross‑linking of peptidoglycan strands, weakening the wall and causing osmotic lysis of actively dividing bacteria, particularly Gram‑positive organisms.

The dosage and administration schedule for Natriumbenzylpenicilline Sandoz are determined by the prescribing clinician based on the infection type, severity, patient age, weight, renal function and route of administration. The prescriber sets the exact dose and frequency.

Safety data for benzylpenicillin sodium in pregnancy and lactation are limited. It should be used only if the potential benefit justifies any potential risk to the fetus or infant. Women who are pregnant, planning pregnancy, or breastfeeding should discuss risks and alternatives with their healthcare provider.

To order, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain if needed) and any required import documentation.

Natriumbenzylpenicilline Sandoz delivers benzylpenicillin sodium, a narrow‑spectrum, time‑dependent bactericidal agent. Compared with broader‑spectrum penicillins such as ampicillin or amoxicillin, it has a lower risk of resistance development but a narrower range of activity, making it ideal for infections caused by susceptible Gram‑positive organisms.

Store the sterile powder for injection at temperatures below 25 °C, in its original packaging, protected from moisture and light. Do not expose to excessive heat or humidity. Reconstitute only with the diluent specified in the product label and use according to aseptic technique.

The product is supplied as a sterile powder for solution for injection. It can be administered intra‑articularly, intramuscularly or intrapleurally, depending on the clinical indication. Reconstitution and injection technique should follow the prescribing information and local clinical guidelines.

The most serious risks include severe allergic reactions such as anaphylaxis, life‑threatening skin reactions (Stevens‑Johnson syndrome, toxic epidermal necrolysis), Clostridioides difficile‑associated colitis, and rare hematologic disorders like hemolytic anemia. Prompt medical attention is required if any of these occur.

Patients with a documented severe hypersensitivity to benzylpenicillin, other penicillins, or any component of the formulation should not receive this product. Caution is also advised for individuals with a history of severe allergic reactions to beta‑lactam antibiotics.